GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PositiveID Corp (OTCPK:PSID) » Definitions » Gross Profit

PositiveID (PositiveID) Gross Profit : $1.61 Mil (TTM As of Mar. 2018)


View and export this data going back to 2007. Start your Free Trial

What is PositiveID Gross Profit?

PositiveID's gross profit for the three months ended in Mar. 2018 was $0.19 Mil. PositiveID's gross profit for the trailing twelve months (TTM) ended in Mar. 2018 was $1.61 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. PositiveID's gross profit for the three months ended in Mar. 2018 was $0.19 Mil. PositiveID's Revenue for the three months ended in Mar. 2018 was $0.42 Mil. Therefore, PositiveID's Gross Margin % for the quarter that ended in Mar. 2018 was 45.71%.

PositiveID had a gross margin of 45.71% for the quarter that ended in Mar. 2018 => Durable competitive advantage


PositiveID Gross Profit Historical Data

The historical data trend for PositiveID's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PositiveID Gross Profit Chart

PositiveID Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.65 2.61 2.02 1.85

PositiveID Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.47 0.53 0.42 0.19

Competitive Comparison of PositiveID's Gross Profit

For the Diagnostics & Research subindustry, PositiveID's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PositiveID's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PositiveID's Gross Profit distribution charts can be found below:

* The bar in red indicates where PositiveID's Gross Profit falls into.



PositiveID Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

PositiveID's Gross Profit for the fiscal year that ended in Dec. 2017 is calculated as

Gross Profit (A: Dec. 2017 )=Revenue - Cost of Goods Sold
=5.359 - 3.514
=1.85

PositiveID's Gross Profit for the quarter that ended in Mar. 2018 is calculated as

Gross Profit (Q: Mar. 2018 )=Revenue - Cost of Goods Sold
=0.42 - 0.228
=0.19

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.61 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

PositiveID's Gross Margin % for the quarter that ended in Mar. 2018 is calculated as

Gross Margin % (Q: Mar. 2018 )=Gross Profit (Q: Mar. 2018 ) / Revenue (Q: Mar. 2018 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.19 / 0.42
=45.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


PositiveID  (OTCPK:PSID) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PositiveID had a gross margin of 45.71% for the quarter that ended in Mar. 2018 => Durable competitive advantage


PositiveID Gross Profit Related Terms

Thank you for viewing the detailed overview of PositiveID's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


PositiveID (PositiveID) Business Description

Traded in Other Exchanges
N/A
Address
1690 South Congress Avenue, Suite 201, Delray Beach, FL, USA, 33445
PositiveID Corp is a life science tools and diagnostics company. It specializes in the biological detection and molecular diagnostic systems for homeland defense and the global healthcare market. The business activity of the firm includes the development of microfluidic systems in order to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need through its subsidiary. Further, it is also involved in the development of FireflyDX family of products, automated pathogen detection system for rapid diagnostics, both for clinical and point-of-need applications. In addition, it also manufactures specialty technology vehicles focused primarily on mobile laboratory and communications applications. All the activities are carried out through the US.
Executives
Ned L Siegel director 600 WILSHIRE BOULEVARD, LOS ANGELES CA 90017
Michael E Krawitz director 1690 S CONGRESS AVE, STE 201, DELRAY BEACH FL 33445
Barry M Edelstein director 1100 GREEN VALLEY ROAD, BRYN MAWR PA 19010
Scott R Silverman other: Former 10% Owner
Marxe Austin W & Greenhouse David M 10 percent owner C/O SPECIAL SITUATIONS FUNDS, 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Weaver Constance K director 2900 ESPERANZA CROSSING, 2ND FLOOR, AUSTIN TX 78758
Tommy G Thompson director 7711 CARONDELET, ST. LOUIS MO 63105

PositiveID (PositiveID) Headlines

From GuruFocus